Creative Biolabs Announces Innovative Technologies for Functional Liposomal Development

Creative Biolabs focuses on developing a variety of liposomes, employing a range of development processes and platforms with the aim of improving the effectiveness and preserving the integrity of the lipid drug delivery systems.
New York, USA - November 12, 2024 - Drug delivery systems employing lipid bilayers, or liposomes, have been used also to enhance the bioavailability and efficacy of numerous therapeutics. Creative Biolabs identified it is crucial to develop more effective carriers to enhance the specificity and efficacy of therapeutics. This company recently announced new developments in liposomal technology with a greater affinity for therapeutic efficacy in gene delivery and beyond.

Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg

"Liposomal formulation is advantageous since liposomes are non-toxic and can hold different drug substances. For instance, in gene therapy, one of the aspects of our research is employing cationic liposomes [https://www.creative-biolabs.com/lipid-based-delivery/cationic-liposome-development-service.htm] to deliver genetic materials safely," said a scientist from this company.

Creative Biolabs' advanced cationic liposomes offer enhanced cellular uptake, making them ideal for therapeutic research.

"In addition to cationic liposomes, we also provide long circulating liposomes [https://www.creative-biolabs.com/lipid-based-delivery/long-circulating-liposome-development-service.htm] that could prolong the drugs in the blood with a very significant half-life. Advanced platforms and technologies are employed to provide high-precision formulation, stability test, and scalability for each project's specific requirements, including a high-throughput liposome formulation platform, and in vitro and in vivo stability platforms," added the scientist.

In addition to the above-mentioned functional liposomes, several other liposomes including the conventional liposome [https://www.creative-biolabs.com/lipid-based-delivery/conventional-liposome-development-service.htm] and magnetic liposome [https://www.creative-biolabs.com/lipid-based-delivery/magnetic-liposome-development-service.htm] are also important for application in drug delivery.

"Our liposome development services are aimed at optimizing and customizing magnetic liposome formulations for various pharmaceutical and research purposes," said an expert, "For instance, we offer design variation of the lipid composition, antibiotic pegylation, micron size, and surface properties for specific projects."

With a customer-oriented approach as its core principle, this CRO takes pride in offering almost exclusively bespoke services. Apart from employing state-of-the-art technologies, we also focus on developing the solutions as per the requirements. From the very first idea and even till the very last stage of the process when the product is delivered, support teams from their side will be available and help clients wherever help is needed.

Creative Biolabs stands at the forefront of liposomal technology, ready to enhance drug delivery methods with innovative solutions. For more information about its advancements in functional liposomal development, please visit https://www.creative-biolabs.com/lipid-based-delivery.

About Creative Biolabs

As the world's leading Contract Research Organization specializing in drug development, Creative Biolabs has the mission of helping researchers and pharmaceutical companies all over the world promote drug development. This organization, backed up by over ten years of experience in the segment tackles the development of liposomal carrier systems in various ways using the best available tools and solution platforms.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email [http://www.universalpressrelease.com/?pr=creative-biolabs-announces-innovative-technologies-for-functional-liposomal-development]
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/lipid-based-delivery



This release was published on openPR.